Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun 28;11:5745–5756. doi: 10.2147/CMAR.S197455

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Xiong et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Profiles of the selected panel of genes in the cell cycle, RTK/RAS/PI(3)K, and Wnt signaling pathways and their relationship to survival and recurrence of HCC. The profiles of the significantly altered genes in the cell cycle, RTK/RAS/PI(3)K, and Wnt signaling pathways were compared between the recurrent HCC group and the non-recurrent or naïve HCC group. (A) Comparison of profiles of the significantly altered genes in the cell cycle, RTK/RAS/PI(3)K, and Wnt signaling pathways between the recurrent and non-recurrent HCC groups. (B) Survival plots for the mutated group and non-mutated group for the selected genes in the cell cycle, RTK/RAS/PI(3)K, and Wnt signaling pathways. (C) Recurrence plot for the mutated group and non-mutated group for the selected genes in the cell cycle, RTK/RAS/PI(3)K, and Wnt signaling pathways.

Abbreviation: HCC, hepatocellular carcinoma.